Global Biosimilar and Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biosimilar and Biologics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Biosimilar and Biologics industry chain, the market status of Autoimmune Diseases (Monoclonal Antibody, Vaccines), Infectious Diseases (Monoclonal Antibody, Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar and Biologics.
Regionally, the report analyzes the Biosimilar and Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar and Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar and Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar and Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibody, Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar and Biologics market.
Regional Analysis: The report involves examining the Biosimilar and Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar and Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar and Biologics:
Company Analysis: Report covers individual Biosimilar and Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar and Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Autoimmune Diseases, Infectious Diseases).
Technology Analysis: Report covers specific technologies relevant to Biosimilar and Biologics. It assesses the current state, advancements, and potential future developments in Biosimilar and Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar and Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar and Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Biosimilar and Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosimilar and Biologics, with price, sales, revenue and global market share of Biosimilar and Biologics from 2019 to 2024.
Chapter 3, the Biosimilar and Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar and Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biosimilar and Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosimilar and Biologics.
Chapter 14 and 15, to describe Biosimilar and Biologics sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Biosimilar and Biologics industry chain, the market status of Autoimmune Diseases (Monoclonal Antibody, Vaccines), Infectious Diseases (Monoclonal Antibody, Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar and Biologics.
Regionally, the report analyzes the Biosimilar and Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar and Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar and Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar and Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibody, Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar and Biologics market.
Regional Analysis: The report involves examining the Biosimilar and Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar and Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar and Biologics:
Company Analysis: Report covers individual Biosimilar and Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar and Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Autoimmune Diseases, Infectious Diseases).
Technology Analysis: Report covers specific technologies relevant to Biosimilar and Biologics. It assesses the current state, advancements, and potential future developments in Biosimilar and Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar and Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar and Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Monoclonal Antibody
- Vaccines
- Recombinant Insulin
- Growth Factors
- Immune Modulators
- Fusion Protein
- Erythoprotein
- Other
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Disorders
- Other
- Pfizer
- Roche AG
- AbbVie
- Novartis AG
- Merck
- Bristol Myers Squibb
- GSK
- AstraZeneca
- Eli Lilly
- Bayer
- Gilead Sciences
- Amgen
- Boehringer Ingelheim
- Novo Nordisk
- Viatris
- Johnson
- Sanofi Winthrop Industries
- Serum Institute of India
- Biocon
- Intas Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biosimilar and Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosimilar and Biologics, with price, sales, revenue and global market share of Biosimilar and Biologics from 2019 to 2024.
Chapter 3, the Biosimilar and Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar and Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biosimilar and Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosimilar and Biologics.
Chapter 14 and 15, to describe Biosimilar and Biologics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar and Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biosimilar and Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monoclonal Antibody
1.3.3 Vaccines
1.3.4 Recombinant Insulin
1.3.5 Growth Factors
1.3.6 Immune Modulators
1.3.7 Fusion Protein
1.3.8 Erythoprotein
1.3.9 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Biosimilar and Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Autoimmune Diseases
1.4.3 Infectious Diseases
1.4.4 Cardiovascular Disorders
1.4.5 Other
1.5 Global Biosimilar and Biologics Market Size & Forecast
1.5.1 Global Biosimilar and Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biosimilar and Biologics Sales Quantity (2019-2030)
1.5.3 Global Biosimilar and Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biosimilar and Biologics Product and Services
2.1.4 Pfizer Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Roche AG
2.2.1 Roche AG Details
2.2.2 Roche AG Major Business
2.2.3 Roche AG Biosimilar and Biologics Product and Services
2.2.4 Roche AG Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche AG Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biosimilar and Biologics Product and Services
2.3.4 AbbVie Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AbbVie Recent Developments/Updates
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Biosimilar and Biologics Product and Services
2.4.4 Novartis AG Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis AG Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Biosimilar and Biologics Product and Services
2.5.4 Merck Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments/Updates
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb Biosimilar and Biologics Product and Services
2.6.4 Bristol Myers Squibb Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bristol Myers Squibb Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Biosimilar and Biologics Product and Services
2.7.4 GSK Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSK Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Biosimilar and Biologics Product and Services
2.8.4 AstraZeneca Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Biosimilar and Biologics Product and Services
2.9.4 Eli Lilly Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business
2.10.3 Bayer Biosimilar and Biologics Product and Services
2.10.4 Bayer Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bayer Recent Developments/Updates
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Biosimilar and Biologics Product and Services
2.11.4 Gilead Sciences Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Gilead Sciences Recent Developments/Updates
2.12 Amgen
2.12.1 Amgen Details
2.12.2 Amgen Major Business
2.12.3 Amgen Biosimilar and Biologics Product and Services
2.12.4 Amgen Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Amgen Recent Developments/Updates
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Biosimilar and Biologics Product and Services
2.13.4 Boehringer Ingelheim Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Boehringer Ingelheim Recent Developments/Updates
2.14 Novo Nordisk
2.14.1 Novo Nordisk Details
2.14.2 Novo Nordisk Major Business
2.14.3 Novo Nordisk Biosimilar and Biologics Product and Services
2.14.4 Novo Nordisk Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Novo Nordisk Recent Developments/Updates
2.15 Viatris
2.15.1 Viatris Details
2.15.2 Viatris Major Business
2.15.3 Viatris Biosimilar and Biologics Product and Services
2.15.4 Viatris Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Viatris Recent Developments/Updates
2.16 Johnson
2.16.1 Johnson Details
2.16.2 Johnson Major Business
2.16.3 Johnson Biosimilar and Biologics Product and Services
2.16.4 Johnson Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Johnson Recent Developments/Updates
2.17 Sanofi Winthrop Industries
2.17.1 Sanofi Winthrop Industries Details
2.17.2 Sanofi Winthrop Industries Major Business
2.17.3 Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
2.17.4 Sanofi Winthrop Industries Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sanofi Winthrop Industries Recent Developments/Updates
2.18 Serum Institute of India
2.18.1 Serum Institute of India Details
2.18.2 Serum Institute of India Major Business
2.18.3 Serum Institute of India Biosimilar and Biologics Product and Services
2.18.4 Serum Institute of India Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Serum Institute of India Recent Developments/Updates
2.19 Biocon
2.19.1 Biocon Details
2.19.2 Biocon Major Business
2.19.3 Biocon Biosimilar and Biologics Product and Services
2.19.4 Biocon Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Biocon Recent Developments/Updates
2.20 Intas Pharmaceuticals
2.20.1 Intas Pharmaceuticals Details
2.20.2 Intas Pharmaceuticals Major Business
2.20.3 Intas Pharmaceuticals Biosimilar and Biologics Product and Services
2.20.4 Intas Pharmaceuticals Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Intas Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOSIMILAR AND BIOLOGICS BY MANUFACTURER
3.1 Global Biosimilar and Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biosimilar and Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Biosimilar and Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biosimilar and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biosimilar and Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Biosimilar and Biologics Manufacturer Market Share in 2023
3.5 Biosimilar and Biologics Market: Overall Company Footprint Analysis
3.5.1 Biosimilar and Biologics Market: Region Footprint
3.5.2 Biosimilar and Biologics Market: Company Product Type Footprint
3.5.3 Biosimilar and Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biosimilar and Biologics Market Size by Region
4.1.1 Global Biosimilar and Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Biosimilar and Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Biosimilar and Biologics Average Price by Region (2019-2030)
4.2 North America Biosimilar and Biologics Consumption Value (2019-2030)
4.3 Europe Biosimilar and Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Biosimilar and Biologics Consumption Value (2019-2030)
4.5 South America Biosimilar and Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Biosimilar and Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biosimilar and Biologics Sales Quantity by Type (2019-2030)
5.2 Global Biosimilar and Biologics Consumption Value by Type (2019-2030)
5.3 Global Biosimilar and Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biosimilar and Biologics Sales Quantity by Application (2019-2030)
6.2 Global Biosimilar and Biologics Consumption Value by Application (2019-2030)
6.3 Global Biosimilar and Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biosimilar and Biologics Sales Quantity by Type (2019-2030)
7.2 North America Biosimilar and Biologics Sales Quantity by Application (2019-2030)
7.3 North America Biosimilar and Biologics Market Size by Country
7.3.1 North America Biosimilar and Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Biosimilar and Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biosimilar and Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Biosimilar and Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Biosimilar and Biologics Market Size by Country
8.3.1 Europe Biosimilar and Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Biosimilar and Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biosimilar and Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biosimilar and Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biosimilar and Biologics Market Size by Region
9.3.1 Asia-Pacific Biosimilar and Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biosimilar and Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biosimilar and Biologics Sales Quantity by Type (2019-2030)
10.2 South America Biosimilar and Biologics Sales Quantity by Application (2019-2030)
10.3 South America Biosimilar and Biologics Market Size by Country
10.3.1 South America Biosimilar and Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Biosimilar and Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biosimilar and Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biosimilar and Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biosimilar and Biologics Market Size by Country
11.3.1 Middle East & Africa Biosimilar and Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biosimilar and Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biosimilar and Biologics Market Drivers
12.2 Biosimilar and Biologics Market Restraints
12.3 Biosimilar and Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biosimilar and Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biosimilar and Biologics
13.3 Biosimilar and Biologics Production Process
13.4 Biosimilar and Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biosimilar and Biologics Typical Distributors
14.3 Biosimilar and Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Biosimilar and Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biosimilar and Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monoclonal Antibody
1.3.3 Vaccines
1.3.4 Recombinant Insulin
1.3.5 Growth Factors
1.3.6 Immune Modulators
1.3.7 Fusion Protein
1.3.8 Erythoprotein
1.3.9 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Biosimilar and Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Autoimmune Diseases
1.4.3 Infectious Diseases
1.4.4 Cardiovascular Disorders
1.4.5 Other
1.5 Global Biosimilar and Biologics Market Size & Forecast
1.5.1 Global Biosimilar and Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biosimilar and Biologics Sales Quantity (2019-2030)
1.5.3 Global Biosimilar and Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biosimilar and Biologics Product and Services
2.1.4 Pfizer Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Roche AG
2.2.1 Roche AG Details
2.2.2 Roche AG Major Business
2.2.3 Roche AG Biosimilar and Biologics Product and Services
2.2.4 Roche AG Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche AG Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biosimilar and Biologics Product and Services
2.3.4 AbbVie Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AbbVie Recent Developments/Updates
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Biosimilar and Biologics Product and Services
2.4.4 Novartis AG Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis AG Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Biosimilar and Biologics Product and Services
2.5.4 Merck Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments/Updates
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb Biosimilar and Biologics Product and Services
2.6.4 Bristol Myers Squibb Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bristol Myers Squibb Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Biosimilar and Biologics Product and Services
2.7.4 GSK Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSK Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Biosimilar and Biologics Product and Services
2.8.4 AstraZeneca Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Biosimilar and Biologics Product and Services
2.9.4 Eli Lilly Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business
2.10.3 Bayer Biosimilar and Biologics Product and Services
2.10.4 Bayer Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bayer Recent Developments/Updates
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Biosimilar and Biologics Product and Services
2.11.4 Gilead Sciences Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Gilead Sciences Recent Developments/Updates
2.12 Amgen
2.12.1 Amgen Details
2.12.2 Amgen Major Business
2.12.3 Amgen Biosimilar and Biologics Product and Services
2.12.4 Amgen Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Amgen Recent Developments/Updates
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Biosimilar and Biologics Product and Services
2.13.4 Boehringer Ingelheim Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Boehringer Ingelheim Recent Developments/Updates
2.14 Novo Nordisk
2.14.1 Novo Nordisk Details
2.14.2 Novo Nordisk Major Business
2.14.3 Novo Nordisk Biosimilar and Biologics Product and Services
2.14.4 Novo Nordisk Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Novo Nordisk Recent Developments/Updates
2.15 Viatris
2.15.1 Viatris Details
2.15.2 Viatris Major Business
2.15.3 Viatris Biosimilar and Biologics Product and Services
2.15.4 Viatris Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Viatris Recent Developments/Updates
2.16 Johnson
2.16.1 Johnson Details
2.16.2 Johnson Major Business
2.16.3 Johnson Biosimilar and Biologics Product and Services
2.16.4 Johnson Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Johnson Recent Developments/Updates
2.17 Sanofi Winthrop Industries
2.17.1 Sanofi Winthrop Industries Details
2.17.2 Sanofi Winthrop Industries Major Business
2.17.3 Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
2.17.4 Sanofi Winthrop Industries Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sanofi Winthrop Industries Recent Developments/Updates
2.18 Serum Institute of India
2.18.1 Serum Institute of India Details
2.18.2 Serum Institute of India Major Business
2.18.3 Serum Institute of India Biosimilar and Biologics Product and Services
2.18.4 Serum Institute of India Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Serum Institute of India Recent Developments/Updates
2.19 Biocon
2.19.1 Biocon Details
2.19.2 Biocon Major Business
2.19.3 Biocon Biosimilar and Biologics Product and Services
2.19.4 Biocon Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Biocon Recent Developments/Updates
2.20 Intas Pharmaceuticals
2.20.1 Intas Pharmaceuticals Details
2.20.2 Intas Pharmaceuticals Major Business
2.20.3 Intas Pharmaceuticals Biosimilar and Biologics Product and Services
2.20.4 Intas Pharmaceuticals Biosimilar and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Intas Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOSIMILAR AND BIOLOGICS BY MANUFACTURER
3.1 Global Biosimilar and Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biosimilar and Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Biosimilar and Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biosimilar and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biosimilar and Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Biosimilar and Biologics Manufacturer Market Share in 2023
3.5 Biosimilar and Biologics Market: Overall Company Footprint Analysis
3.5.1 Biosimilar and Biologics Market: Region Footprint
3.5.2 Biosimilar and Biologics Market: Company Product Type Footprint
3.5.3 Biosimilar and Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biosimilar and Biologics Market Size by Region
4.1.1 Global Biosimilar and Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Biosimilar and Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Biosimilar and Biologics Average Price by Region (2019-2030)
4.2 North America Biosimilar and Biologics Consumption Value (2019-2030)
4.3 Europe Biosimilar and Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Biosimilar and Biologics Consumption Value (2019-2030)
4.5 South America Biosimilar and Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Biosimilar and Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biosimilar and Biologics Sales Quantity by Type (2019-2030)
5.2 Global Biosimilar and Biologics Consumption Value by Type (2019-2030)
5.3 Global Biosimilar and Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biosimilar and Biologics Sales Quantity by Application (2019-2030)
6.2 Global Biosimilar and Biologics Consumption Value by Application (2019-2030)
6.3 Global Biosimilar and Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biosimilar and Biologics Sales Quantity by Type (2019-2030)
7.2 North America Biosimilar and Biologics Sales Quantity by Application (2019-2030)
7.3 North America Biosimilar and Biologics Market Size by Country
7.3.1 North America Biosimilar and Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Biosimilar and Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biosimilar and Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Biosimilar and Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Biosimilar and Biologics Market Size by Country
8.3.1 Europe Biosimilar and Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Biosimilar and Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biosimilar and Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biosimilar and Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biosimilar and Biologics Market Size by Region
9.3.1 Asia-Pacific Biosimilar and Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biosimilar and Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biosimilar and Biologics Sales Quantity by Type (2019-2030)
10.2 South America Biosimilar and Biologics Sales Quantity by Application (2019-2030)
10.3 South America Biosimilar and Biologics Market Size by Country
10.3.1 South America Biosimilar and Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Biosimilar and Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biosimilar and Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biosimilar and Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biosimilar and Biologics Market Size by Country
11.3.1 Middle East & Africa Biosimilar and Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biosimilar and Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biosimilar and Biologics Market Drivers
12.2 Biosimilar and Biologics Market Restraints
12.3 Biosimilar and Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biosimilar and Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biosimilar and Biologics
13.3 Biosimilar and Biologics Production Process
13.4 Biosimilar and Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biosimilar and Biologics Typical Distributors
14.3 Biosimilar and Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilar and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Biosimilar and Biologics Product and Services
Table 6. Pfizer Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Roche AG Basic Information, Manufacturing Base and Competitors
Table 9. Roche AG Major Business
Table 10. Roche AG Biosimilar and Biologics Product and Services
Table 11. Roche AG Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Roche AG Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Biosimilar and Biologics Product and Services
Table 16. AbbVie Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. AbbVie Recent Developments/Updates
Table 18. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 19. Novartis AG Major Business
Table 20. Novartis AG Biosimilar and Biologics Product and Services
Table 21. Novartis AG Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis AG Recent Developments/Updates
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Biosimilar and Biologics Product and Services
Table 26. Merck Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merck Recent Developments/Updates
Table 28. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 29. Bristol Myers Squibb Major Business
Table 30. Bristol Myers Squibb Biosimilar and Biologics Product and Services
Table 31. Bristol Myers Squibb Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bristol Myers Squibb Recent Developments/Updates
Table 33. GSK Basic Information, Manufacturing Base and Competitors
Table 34. GSK Major Business
Table 35. GSK Biosimilar and Biologics Product and Services
Table 36. GSK Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GSK Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Biosimilar and Biologics Product and Services
Table 41. AstraZeneca Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Biosimilar and Biologics Product and Services
Table 46. Eli Lilly Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Bayer Basic Information, Manufacturing Base and Competitors
Table 49. Bayer Major Business
Table 50. Bayer Biosimilar and Biologics Product and Services
Table 51. Bayer Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Bayer Recent Developments/Updates
Table 53. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Gilead Sciences Major Business
Table 55. Gilead Sciences Biosimilar and Biologics Product and Services
Table 56. Gilead Sciences Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Gilead Sciences Recent Developments/Updates
Table 58. Amgen Basic Information, Manufacturing Base and Competitors
Table 59. Amgen Major Business
Table 60. Amgen Biosimilar and Biologics Product and Services
Table 61. Amgen Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Amgen Recent Developments/Updates
Table 63. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 64. Boehringer Ingelheim Major Business
Table 65. Boehringer Ingelheim Biosimilar and Biologics Product and Services
Table 66. Boehringer Ingelheim Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Boehringer Ingelheim Recent Developments/Updates
Table 68. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 69. Novo Nordisk Major Business
Table 70. Novo Nordisk Biosimilar and Biologics Product and Services
Table 71. Novo Nordisk Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Novo Nordisk Recent Developments/Updates
Table 73. Viatris Basic Information, Manufacturing Base and Competitors
Table 74. Viatris Major Business
Table 75. Viatris Biosimilar and Biologics Product and Services
Table 76. Viatris Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Viatris Recent Developments/Updates
Table 78. Johnson Basic Information, Manufacturing Base and Competitors
Table 79. Johnson Major Business
Table 80. Johnson Biosimilar and Biologics Product and Services
Table 81. Johnson Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Johnson Recent Developments/Updates
Table 83. Sanofi Winthrop Industries Basic Information, Manufacturing Base and Competitors
Table 84. Sanofi Winthrop Industries Major Business
Table 85. Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
Table 86. Sanofi Winthrop Industries Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Sanofi Winthrop Industries Recent Developments/Updates
Table 88. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 89. Serum Institute of India Major Business
Table 90. Serum Institute of India Biosimilar and Biologics Product and Services
Table 91. Serum Institute of India Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Serum Institute of India Recent Developments/Updates
Table 93. Biocon Basic Information, Manufacturing Base and Competitors
Table 94. Biocon Major Business
Table 95. Biocon Biosimilar and Biologics Product and Services
Table 96. Biocon Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Biocon Recent Developments/Updates
Table 98. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Intas Pharmaceuticals Major Business
Table 100. Intas Pharmaceuticals Biosimilar and Biologics Product and Services
Table 101. Intas Pharmaceuticals Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Intas Pharmaceuticals Recent Developments/Updates
Table 103. Global Biosimilar and Biologics Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 104. Global Biosimilar and Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Biosimilar and Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 106. Market Position of Manufacturers in Biosimilar and Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Biosimilar and Biologics Production Site of Key Manufacturer
Table 108. Biosimilar and Biologics Market: Company Product Type Footprint
Table 109. Biosimilar and Biologics Market: Company Product Application Footprint
Table 110. Biosimilar and Biologics New Market Entrants and Barriers to Market Entry
Table 111. Biosimilar and Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Biosimilar and Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 113. Global Biosimilar and Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 114. Global Biosimilar and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Biosimilar and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Biosimilar and Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 117. Global Biosimilar and Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 118. Global Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Global Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Global Biosimilar and Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Biosimilar and Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Biosimilar and Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 123. Global Biosimilar and Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 124. Global Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Global Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Global Biosimilar and Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Biosimilar and Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Biosimilar and Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 129. Global Biosimilar and Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 130. North America Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 131. North America Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 132. North America Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 133. North America Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 134. North America Biosimilar and Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 135. North America Biosimilar and Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 136. North America Biosimilar and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Biosimilar and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Europe Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Europe Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 141. Europe Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 142. Europe Biosimilar and Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 143. Europe Biosimilar and Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 144. Europe Biosimilar and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Biosimilar and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 147. Asia-Pacific Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 148. Asia-Pacific Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 149. Asia-Pacific Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 150. Asia-Pacific Biosimilar and Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 151. Asia-Pacific Biosimilar and Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 152. Asia-Pacific Biosimilar and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Biosimilar and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 155. South America Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 156. South America Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 157. South America Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 158. South America Biosimilar and Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 159. South America Biosimilar and Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 160. South America Biosimilar and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Biosimilar and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 163. Middle East & Africa Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 164. Middle East & Africa Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 165. Middle East & Africa Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 166. Middle East & Africa Biosimilar and Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 167. Middle East & Africa Biosimilar and Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 168. Middle East & Africa Biosimilar and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Biosimilar and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Biosimilar and Biologics Raw Material
Table 171. Key Manufacturers of Biosimilar and Biologics Raw Materials
Table 172. Biosimilar and Biologics Typical Distributors
Table 173. Biosimilar and Biologics Typical Customers
LIST OF FIGURE
s
Figure 1. Biosimilar and Biologics Picture
Figure 2. Global Biosimilar and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar and Biologics Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibody Examples
Figure 5. Vaccines Examples
Figure 6. Recombinant Insulin Examples
Figure 7. Growth Factors Examples
Figure 8. Immune Modulators Examples
Figure 9. Fusion Protein Examples
Figure 10. Erythoprotein Examples
Figure 11. Other Examples
Figure 12. Global Biosimilar and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 13. Global Biosimilar and Biologics Consumption Value Market Share by Application in 2023
Figure 14. Autoimmune Diseases Examples
Figure 15. Infectious Diseases Examples
Figure 16. Cardiovascular Disorders Examples
Figure 17. Other Examples
Figure 18. Global Biosimilar and Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Biosimilar and Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Biosimilar and Biologics Sales Quantity (2019-2030) & (K Units)
Figure 21. Global Biosimilar and Biologics Average Price (2019-2030) & (US$/Unit)
Figure 22. Global Biosimilar and Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 23. Global Biosimilar and Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 24. Producer Shipments of Biosimilar and Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 25. Top 3 Biosimilar and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Top 6 Biosimilar and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Global Biosimilar and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 28. Global Biosimilar and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 29. North America Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 30. Europe Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 31. Asia-Pacific Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 32. South America Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 33. Middle East & Africa Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 34. Global Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Biosimilar and Biologics Consumption Value Market Share by Type (2019-2030)
Figure 36. Global Biosimilar and Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 37. Global Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global Biosimilar and Biologics Consumption Value Market Share by Application (2019-2030)
Figure 39. Global Biosimilar and Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 40. North America Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Biosimilar and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 43. North America Biosimilar and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 44. United States Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Canada Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Mexico Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Europe Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe Biosimilar and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 50. Europe Biosimilar and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 51. Germany Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. France Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. United Kingdom Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Russia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Italy Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Asia-Pacific Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 57. Asia-Pacific Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 58. Asia-Pacific Biosimilar and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 59. Asia-Pacific Biosimilar and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 60. China Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Japan Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Korea Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. India Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Southeast Asia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Australia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. South America Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 67. South America Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 68. South America Biosimilar and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 69. South America Biosimilar and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 70. Brazil Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Argentina Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Middle East & Africa Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 73. Middle East & Africa Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 74. Middle East & Africa Biosimilar and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 75. Middle East & Africa Biosimilar and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 76. Turkey Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Egypt Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Saudi Arabia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. South Africa Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. Biosimilar and Biologics Market Drivers
Figure 81. Biosimilar and Biologics Market Restraints
Figure 82. Biosimilar and Biologics Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Biosimilar and Biologics in 2023
Figure 85. Manufacturing Process Analysis of Biosimilar and Biologics
Figure 86. Biosimilar and Biologics Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Table 1. Global Biosimilar and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Biosimilar and Biologics Product and Services
Table 6. Pfizer Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Roche AG Basic Information, Manufacturing Base and Competitors
Table 9. Roche AG Major Business
Table 10. Roche AG Biosimilar and Biologics Product and Services
Table 11. Roche AG Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Roche AG Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Biosimilar and Biologics Product and Services
Table 16. AbbVie Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. AbbVie Recent Developments/Updates
Table 18. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 19. Novartis AG Major Business
Table 20. Novartis AG Biosimilar and Biologics Product and Services
Table 21. Novartis AG Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis AG Recent Developments/Updates
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Biosimilar and Biologics Product and Services
Table 26. Merck Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merck Recent Developments/Updates
Table 28. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 29. Bristol Myers Squibb Major Business
Table 30. Bristol Myers Squibb Biosimilar and Biologics Product and Services
Table 31. Bristol Myers Squibb Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bristol Myers Squibb Recent Developments/Updates
Table 33. GSK Basic Information, Manufacturing Base and Competitors
Table 34. GSK Major Business
Table 35. GSK Biosimilar and Biologics Product and Services
Table 36. GSK Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GSK Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Biosimilar and Biologics Product and Services
Table 41. AstraZeneca Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Biosimilar and Biologics Product and Services
Table 46. Eli Lilly Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Bayer Basic Information, Manufacturing Base and Competitors
Table 49. Bayer Major Business
Table 50. Bayer Biosimilar and Biologics Product and Services
Table 51. Bayer Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Bayer Recent Developments/Updates
Table 53. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Gilead Sciences Major Business
Table 55. Gilead Sciences Biosimilar and Biologics Product and Services
Table 56. Gilead Sciences Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Gilead Sciences Recent Developments/Updates
Table 58. Amgen Basic Information, Manufacturing Base and Competitors
Table 59. Amgen Major Business
Table 60. Amgen Biosimilar and Biologics Product and Services
Table 61. Amgen Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Amgen Recent Developments/Updates
Table 63. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 64. Boehringer Ingelheim Major Business
Table 65. Boehringer Ingelheim Biosimilar and Biologics Product and Services
Table 66. Boehringer Ingelheim Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Boehringer Ingelheim Recent Developments/Updates
Table 68. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 69. Novo Nordisk Major Business
Table 70. Novo Nordisk Biosimilar and Biologics Product and Services
Table 71. Novo Nordisk Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Novo Nordisk Recent Developments/Updates
Table 73. Viatris Basic Information, Manufacturing Base and Competitors
Table 74. Viatris Major Business
Table 75. Viatris Biosimilar and Biologics Product and Services
Table 76. Viatris Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Viatris Recent Developments/Updates
Table 78. Johnson Basic Information, Manufacturing Base and Competitors
Table 79. Johnson Major Business
Table 80. Johnson Biosimilar and Biologics Product and Services
Table 81. Johnson Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Johnson Recent Developments/Updates
Table 83. Sanofi Winthrop Industries Basic Information, Manufacturing Base and Competitors
Table 84. Sanofi Winthrop Industries Major Business
Table 85. Sanofi Winthrop Industries Biosimilar and Biologics Product and Services
Table 86. Sanofi Winthrop Industries Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Sanofi Winthrop Industries Recent Developments/Updates
Table 88. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 89. Serum Institute of India Major Business
Table 90. Serum Institute of India Biosimilar and Biologics Product and Services
Table 91. Serum Institute of India Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Serum Institute of India Recent Developments/Updates
Table 93. Biocon Basic Information, Manufacturing Base and Competitors
Table 94. Biocon Major Business
Table 95. Biocon Biosimilar and Biologics Product and Services
Table 96. Biocon Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Biocon Recent Developments/Updates
Table 98. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Intas Pharmaceuticals Major Business
Table 100. Intas Pharmaceuticals Biosimilar and Biologics Product and Services
Table 101. Intas Pharmaceuticals Biosimilar and Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Intas Pharmaceuticals Recent Developments/Updates
Table 103. Global Biosimilar and Biologics Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 104. Global Biosimilar and Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Biosimilar and Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 106. Market Position of Manufacturers in Biosimilar and Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Biosimilar and Biologics Production Site of Key Manufacturer
Table 108. Biosimilar and Biologics Market: Company Product Type Footprint
Table 109. Biosimilar and Biologics Market: Company Product Application Footprint
Table 110. Biosimilar and Biologics New Market Entrants and Barriers to Market Entry
Table 111. Biosimilar and Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Biosimilar and Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 113. Global Biosimilar and Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 114. Global Biosimilar and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Biosimilar and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Biosimilar and Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 117. Global Biosimilar and Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 118. Global Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Global Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Global Biosimilar and Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Biosimilar and Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Biosimilar and Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 123. Global Biosimilar and Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 124. Global Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Global Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Global Biosimilar and Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Biosimilar and Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Biosimilar and Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 129. Global Biosimilar and Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 130. North America Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 131. North America Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 132. North America Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 133. North America Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 134. North America Biosimilar and Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 135. North America Biosimilar and Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 136. North America Biosimilar and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Biosimilar and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Europe Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Europe Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 141. Europe Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 142. Europe Biosimilar and Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 143. Europe Biosimilar and Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 144. Europe Biosimilar and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Biosimilar and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 147. Asia-Pacific Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 148. Asia-Pacific Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 149. Asia-Pacific Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 150. Asia-Pacific Biosimilar and Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 151. Asia-Pacific Biosimilar and Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 152. Asia-Pacific Biosimilar and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Biosimilar and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 155. South America Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 156. South America Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 157. South America Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 158. South America Biosimilar and Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 159. South America Biosimilar and Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 160. South America Biosimilar and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Biosimilar and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Biosimilar and Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 163. Middle East & Africa Biosimilar and Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 164. Middle East & Africa Biosimilar and Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 165. Middle East & Africa Biosimilar and Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 166. Middle East & Africa Biosimilar and Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 167. Middle East & Africa Biosimilar and Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 168. Middle East & Africa Biosimilar and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Biosimilar and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Biosimilar and Biologics Raw Material
Table 171. Key Manufacturers of Biosimilar and Biologics Raw Materials
Table 172. Biosimilar and Biologics Typical Distributors
Table 173. Biosimilar and Biologics Typical Customers
LIST OF FIGURE
s
Figure 1. Biosimilar and Biologics Picture
Figure 2. Global Biosimilar and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar and Biologics Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibody Examples
Figure 5. Vaccines Examples
Figure 6. Recombinant Insulin Examples
Figure 7. Growth Factors Examples
Figure 8. Immune Modulators Examples
Figure 9. Fusion Protein Examples
Figure 10. Erythoprotein Examples
Figure 11. Other Examples
Figure 12. Global Biosimilar and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 13. Global Biosimilar and Biologics Consumption Value Market Share by Application in 2023
Figure 14. Autoimmune Diseases Examples
Figure 15. Infectious Diseases Examples
Figure 16. Cardiovascular Disorders Examples
Figure 17. Other Examples
Figure 18. Global Biosimilar and Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Biosimilar and Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Biosimilar and Biologics Sales Quantity (2019-2030) & (K Units)
Figure 21. Global Biosimilar and Biologics Average Price (2019-2030) & (US$/Unit)
Figure 22. Global Biosimilar and Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 23. Global Biosimilar and Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 24. Producer Shipments of Biosimilar and Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 25. Top 3 Biosimilar and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Top 6 Biosimilar and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Global Biosimilar and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 28. Global Biosimilar and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 29. North America Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 30. Europe Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 31. Asia-Pacific Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 32. South America Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 33. Middle East & Africa Biosimilar and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 34. Global Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Biosimilar and Biologics Consumption Value Market Share by Type (2019-2030)
Figure 36. Global Biosimilar and Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 37. Global Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global Biosimilar and Biologics Consumption Value Market Share by Application (2019-2030)
Figure 39. Global Biosimilar and Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 40. North America Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Biosimilar and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 43. North America Biosimilar and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 44. United States Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Canada Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Mexico Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Europe Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe Biosimilar and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 50. Europe Biosimilar and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 51. Germany Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. France Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. United Kingdom Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Russia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Italy Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Asia-Pacific Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 57. Asia-Pacific Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 58. Asia-Pacific Biosimilar and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 59. Asia-Pacific Biosimilar and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 60. China Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Japan Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Korea Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. India Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Southeast Asia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Australia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. South America Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 67. South America Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 68. South America Biosimilar and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 69. South America Biosimilar and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 70. Brazil Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Argentina Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Middle East & Africa Biosimilar and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 73. Middle East & Africa Biosimilar and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 74. Middle East & Africa Biosimilar and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 75. Middle East & Africa Biosimilar and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 76. Turkey Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Egypt Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Saudi Arabia Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. South Africa Biosimilar and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. Biosimilar and Biologics Market Drivers
Figure 81. Biosimilar and Biologics Market Restraints
Figure 82. Biosimilar and Biologics Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Biosimilar and Biologics in 2023
Figure 85. Manufacturing Process Analysis of Biosimilar and Biologics
Figure 86. Biosimilar and Biologics Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
